Ensysce Biosciences, Inc. (ENSC)
USD 6.07
(-4.56%)
USD 6.07
(-4.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.23 Million | 2.52 Million | 3.53 Million | 3.93 Million | 1.76 Million | - |
| Cost of Revenue | 7.58 Million | 19.83 Million | 151.00 | 1.36 Million | 3.32 Million | 1.55 Million |
| Gross Profit | -5.35 Million | -17.31 Million | 3.53 Million | 2.56 Million | -1.56 Million | -1.55 Million |
| Operating Expenses | 5.36 Million | 24.22 Million | 19.87 Million | 1.61 Million | 3.32 Million | 959.24 Thousand |
| Selling, General and Administrative Expenses | 5.36 Million | 6.9 Million | 18.71 Million | 1.15 Million | 3.32 Million | 1.55 Million |
| Research and Development Expenses | 7.58 Million | 19.83 Million | 4.69 Million | 4.38 Million | 3.4 Million | - |
| Other Expenses | -7.58 Million | -2.52 Million | -3.53 Million | -3.93 Million | - | 600 Thousand |
| Cost and Expenses | 12.94 Million | 24.22 Million | 19.87 Million | 1.61 Million | 3.32 Million | 959.24 Thousand |
| Operating Income | -10.71 Million | -24.22 Million | -19.87 Million | -1.61 Million | -3.32 Million | -959.24 Thousand |
| Interest Expense | 353.94 Thousand | 109.52 Thousand | 1.29 Million | 995.49 Thousand | - | - |
| Income Tax Expense | - | 753.87 Thousand | -151.00 | 777.85 Thousand | -555.2 Thousand | 553.91 Thousand |
| Earnings before Tax | -10.62 Million | -24.2 Million | -29.14 Million | -160.87 Thousand | 921.15 Thousand | 2.67 Million |
| Net Income | -10.61 Million | -24.96 Million | -29.14 Million | -938.72 Thousand | 1.47 Million | -1.34 Million |
| Earnings Per Share Basic | -4.69 | -138.73 | -346.90 | -14.29 | 15.02 | -12.91 |
| Earnings Per Share Diluted | -4.69 | -138.73 | -346.90 | -13.65 | 15.02 | -12.91 |
| Weighted Average Shares Outstanding | 2.26 Million | 179.93 Thousand | 84.01 Thousand | 65.7 Thousand | 98.26 Thousand | 104.01 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.26 Million | 179.93 Thousand | 84.01 Thousand | 68.78 Thousand | 98.26 Thousand | 104.01 Thousand |
| Gross Margin | -2.40 | -6.86 | 1.00 | 0.65 | -0.89 | - |
| EBIT Margin | -4.81 | -9.60 | -5.63 | -0.41 | -1.89 | - |
| Profit Margin | -4.76 | -9.89 | -8.25 | -0.24 | 0.84 | - |
| EBITDA | -10.71 Million | -24.22 Million | -19.87 Million | -1.61 Million | 921.15 Thousand | 2.67 Million |
| Earnings Before Tax Margin | -4.81 | -9.60 | -5.63 | -0.41 | -1.89 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 181.79 Thousand | 305.72 Thousand | 2.23 Million | 515.03 Thousand | 435.38 Thousand | 490.47 Thousand |
| Cost of Revenue | 947.22 Thousand | - | 7.58 Million | 3.43 Million | 1.91 Million | 1.64 Million |
| Gross Profit | -765.43 Thousand | 305.72 Thousand | -5.35 Million | -2.92 Million | -1.47 Million | -1.15 Million |
| Operating Expenses | 2.13 Million | 2.14 Million | 12.94 Million | 3.67 Million | 2.7 Million | 2.29 Million |
| Selling, General and Administrative Expenses | 1.19 Million | 1.36 Million | - | 1.43 Million | 1.22 Million | 1.14 Million |
| Research and Development Expenses | 947.22 Thousand | 778.9 Thousand | - | 2.23 Million | 1.91 Million | 1.64 Million |
| Other Expenses | 15.21 Thousand | -25.53 Thousand | - | -7962.00 | 6934.00 | 11.03 Thousand |
| Cost and Expenses | 2.13 Million | 2.14 Million | 12.94 Million | 3.67 Million | 2.7 Million | 2.29 Million |
| Operating Income | -1.95 Million | -1.84 Million | -10.71 Million | -3.15 Million | -2.7 Million | -2.29 Million |
| Interest Expense | 27.56 Thousand | 1.24 Million | -353.94 Thousand | 344.79 Thousand | 7649.00 | - |
| Income Tax Expense | 2.00 | -74.00 | -264.00 | 360.48 Thousand | 6414.00 | -3331.00 |
| Earnings before Tax | -1.96 Million | -3.11 Million | -10.62 Million | -3.5 Million | -2.69 Million | -2.23 Million |
| Net Income | -1.96 Million | -3.11 Million | -10.61 Million | -3.5 Million | -2.68 Million | -2.23 Million |
| Earnings Per Share Basic | -0.22 | -0.55 | - | -1.55 | -0.87 | -0.98 |
| Earnings Per Share Diluted | -0.22 | -0.55 | - | -1.55 | -0.87 | -0.98 |
| Weighted Average Shares Outstanding | 8.81 Million | 5.69 Million | 2.26 Million | 2.26 Million | 3.08 Million | 2.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.81 Million | 5.69 Million | 2.26 Million | 2.26 Million | 3.08 Million | 2.27 Million |
| Gross Margin | -4.21 | 1.00 | -2.40 | -5.68 | -3.40 | -2.35 |
| EBIT Margin | -10.76 | -6.03 | - | -6.14 | -6.20 | -4.65 |
| Profit Margin | -10.82 | -10.19 | -4.76 | -6.80 | -6.18 | -4.56 |
| EBITDA | -1.95 Million | -1.84 Million | - | -3.16 Million | -2.7 Million | -2.28 Million |
| Earnings Before Tax Margin | -10.76 | -6.03 | -4.81 | -6.13 | -6.22 | -4.68 |
6625
2993
IHR
AMG
CYYHF
SGMA